TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast CancerRoisín M. Connolly, Vered Stearns, Jeffrey P. Leal et al.|Journal of Nuclear Medicine|2014Cited by 65
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear MedicineJean-Luc Urbain, Richard L. Wahl, Charlotte Weston et al.|Journal of Nuclear Medicine|2023Cited by 34